We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$177M
AUM Growth
+$18.7M
Cap. Flow
+$5.4M
Cap. Flow %
3.04%
Top 10 Hldgs %
18.89%
Holding
982
New
339
Increased
167
Reduced
226
Closed
62

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$1.5M
2
ARE icon
Alexandria Real Estate Equities
ARE
+$1.48M
3
SON icon
Sonoco
SON
+$1.42M
4
R icon
Ryder
R
+$1.39M
5
AMT icon
American Tower
AMT
+$1.38M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.78M
2
IBM icon
IBM
IBM
+$1.56M
3
INGR icon
Ingredion
INGR
+$1.48M
4
ELV icon
Elevance Health
ELV
+$1.47M
5
MDT icon
Medtronic
MDT
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 20.99%
2 Real Estate 18.63%
3 Industrials 12.95%
4 Healthcare 10.2%
5 Consumer Staples 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
851
Vanguard S&P 500 ETF
VOO
$1.03T
$703 ﹤0.01%
2
RVTY icon
852
Revvity
RVTY
$12.9B
$701 ﹤0.01%
+5
New +$673
SFIX
853
Stitch Fix
SFIX
$530M
$700 ﹤0.01%
225
-2,305
-91% -$8.62K
VYMI icon
854
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
$686 ﹤0.01%
+12
New +$689
PEX icon
855
ProShares Global Listed Private Equity ETF
PEX
$11.5M
$685 ﹤0.01%
+26
New +$676
RIG icon
856
Transocean
RIG
$6.39B
$684 ﹤0.01%
+150
New +$578
ATNM icon
857
Actinium Pharmaceuticals
ATNM
$24.2M
$639 ﹤0.01%
60
HRB icon
858
H&R Block
HRB
$5.82B
$621 ﹤0.01%
+17
New +$691
VRTX icon
859
Vertex Pharmaceuticals
VRTX
$133B
$578 ﹤0.01%
+2
New +$610
CSTE icon
860
Caesarstone
CSTE
$88.2M
$571 ﹤0.01%
100
+71
+245% +$530
LPCN icon
861
Lipocine
LPCN
$17.3M
$560 ﹤0.01%
83
WY icon
862
Weyerhaeuser
WY
$18.2B
$558 ﹤0.01%
+18
New +$558
BFH icon
863
Bread Financial
BFH
$4.38B
$539 ﹤0.01%
14
TCS
864
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$539 ﹤0.01%
+8
New +$579
EVBG
865
DELISTED
Everbridge, Inc. Common Stock
EVBG
$532 ﹤0.01%
+18
New +$552
TTGT icon
866
TechTarget
TTGT
$282M
$529 ﹤0.01%
+12
New +$629
ARNC
867
DELISTED
Arconic Corporation
ARNC
$529 ﹤0.01%
+25
New +$523
EWH icon
868
iShares MSCI Hong Kong ETF
EWH
$1.23B
$525 ﹤0.01%
+25
New +$478
TCON
869
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$474 ﹤0.01%
16
AKTX
870
Akari Therapeutics
AKTX
$13.2M
$472 ﹤0.01%
1
-1
-50% -$414
NGNE icon
871
Neurogene
NGNE
$729M
$471 ﹤0.01%
46
SNCR
872
DELISTED
Synchronoss Technologies
SNCR
$449 ﹤0.01%
81
ONCT
873
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$440 ﹤0.01%
22
AKBA icon
874
Akebia Therapeutics
AKBA
$234M
$436 ﹤0.01%
756
XM
875
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$415 ﹤0.01%
40

Similar funds

Truvestments Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Truvestments Capital held 982 positions worth $177M, up 12% from $159M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital deployed $5.4M of net new capital in Q4 2022, opening 339 new positions and adding to 167 existing holdings. Its largest new stake was Coterra Energy: 54,452 shares worth $1.34M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Real Estate and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $1.78M trimmed.

  • Truvestments Capital's largest Q4 2022 buy was Coterra Energy: 54,452 shares worth $1.34M.
  • Truvestments Capital added most to Alexandria Real Estate Equities in Q4 2022, an estimated $1.48M increase.
  • Truvestments Capital's biggest Q4 2022 reduction was AbbVie, cutting an estimated $1.78M.
  • Truvestments Capital fully exited Twitter, Inc. in Q4 2022, selling an estimated $374K.
  • Truvestments Capital's ten largest holdings make up 19% of its $177M portfolio in Q4 2022.
  • Truvestments Capital opened 339 new positions and closed 62 in Q4 2022.
  • Truvestments Capital's portfolio value rose 12% quarter-over-quarter to $177M.

Based on Truvestments Capital's 13F filing for Q4 2022, filed 14 Feb 2023.